MYOM2 and plasmacytoma: Interestingly, 6/14 (43%) cases showed extraosseous plasmacytomas at relapse -either at a pre-existing EMD background (4 cases) or as de novo presentation of new plasmacytomas (2 cases)- without detectable M-protein or BM infiltration.